Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06480903 | Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy(ClearED) | unknown | — | 10 | The Christie NHS Foundation TrustOTHER | 0 | Jun 28, 2024 | clinicaltrials |
| NCT03694249 | Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence | unknown | Phase 2 | 30 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 27, 2024 |
| clinicaltrials |
| NCT04432857 | AN0025 and Pembrolizumab Combination in Advanced Solid Tumors | unknown | Phase 1 | 63 | Adlai Nortye Biopharma Co., Ltd.INDUSTRY | 2 | Jun 27, 2024 | clinicaltrials |
| NCT05830045 | A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors | unknown | Phase 1 | 180 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 27, 2024 | clinicaltrials |
| NCT06476951 | The Effects of Parent-Child Activity Program on PA of Children With Cancer | unknown | N/A | 54 | Ke LiuOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT06478381 | L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma | unknown | Phase 1 | 22 | Henan Cancer HospitalOTHER_GOV | 1 | Jun 27, 2024 | clinicaltrials |
| NCT06478810 | Ambulatory Surgery After Hepatectomy: Monitoring by Domomedicine Connected Tools and a Dedicated Nurse.(HEPADOM) | unknown | N/A | 20 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT03774134 | Five Year Oncological Outcome After CME for Sigmoid Colon Cancer | unknown | — | 920 | Nordsjaellands HospitalOTHER | 0 | Jun 26, 2024 | clinicaltrials |
| NCT04272658 | PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy(IMMUNOPET2) | unknown | — | 56 | University Hospital, BrestOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT04778579 | Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy(CART19-BE-02) | unknown | Phase 2 | 50 | Sara V. LatorreOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06326892 | Natural Orifice Specimen Extraction in Low Rectal Cancer Surgery(NOSES) | unknown | — | 350 | Istituto Clinico HumanitasOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06472024 | Assessing Manual Acupuncture's Impact on Mucositis From Nasopharynx Cancer Radiotherapy: A Visual Analogue Scale (VAS) and Quality of Life Study | unknown | N/A | 30 | Indonesia UniversityOTHER | 0 | Jun 26, 2024 | clinicaltrials |
| NCT06474780 | Evaluation of The Effect of Virtual Reality Glasses | unknown | — | 900 | Gozde OzOTHER | 0 | Jun 26, 2024 | clinicaltrials |
| NCT06474975 | Intra-SURGerY High-resolution Specimen PET/CT Imager for Margin Assessment in Early-stage Breast Cancer(SURGYPET) | unknown | N/A | 150 | European Institute of OncologyOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06474988 | Characterization of Biophysical and Mechanical Parameters on Skin of Breast Cancer Patients | unknown | — | 150 | European Institute of OncologyOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06475196 | Prospective Cohort Study of Neoadjuvant Therapy With Sintilimab (PD-1 Inhibitor) Combined With Chemotherapy in Resectable ESCC | unknown | — | 90 | Tang-Du HospitalOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06475287 | HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 42 | Fudan UniversityOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06475417 | Neoadjuvant Adebrelimab + DOS in Locally Advanced Resectable Gastric Cancer | unknown | Phase 2 | 42 | Tang-Du HospitalOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06475911 | Impact of Peri-Operative Hyponatremia on Postoperative Outcomes in Major HPB Surgeries for Cancers | unknown | — | 500 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06476535 | Observatory of Patients With MyeloProliferative Neoplasm Treated With Anti-inflammatory Immunotherapy(OPIUM) | unknown | — | 100 | University Hospital, BrestOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT05170230 | The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations | unknown | N/A | 99 | Wael Elbanna ClinicOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT05300438 | Phase I Study of TSN084 in Patients With Advanced Malignant Tumors. | unknown | Phase 1 | 74 | Tyligand Bioscience (Shanghai) LimitedINDUSTRY | 1 | Jun 25, 2024 | clinicaltrials |
| NCT05955443 | iToBoS Prospective Data Acquisition and Feasibility Study (Barcelona)(iToBoS BCN) | unknown | — | 350 | The University of QueenslandOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT06414343 | LATe TreatmENT Related Toxicity in Melanoma (LATENT)(LATENT) | unknown | — | 400 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT06428708 | [18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma | unknown | Early Phase 1 | 30 | Western UniversityOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT06465030 | Identification of Pattern and Factors Affecting Recurrence in Head and Neck Carcinoma | unknown | — | 35 | Sohag UniversityOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT06472505 | Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage | unknown | N/A | 30 | National Taiwan University HospitalOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT06473168 | Mobility Assessment in Multi-morbidity(Multi-mobility) | unknown | — | 55 | Northumbria UniversityOTHER | 0 | Jun 25, 2024 | clinicaltrials |
| NCT06473948 | To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects | unknown | Phase 1 | 27 | JemincareINDUSTRY | 0 | Jun 25, 2024 | clinicaltrials |
| NCT06311695 | Contrast-Enhanced Spectral Mammography (CESM)(CESM) | unknown | Phase 2 | 263 | European Institute of OncologyOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT06471452 | To Live Better After Breast Cancer Treatment | unknown | N/A | 40 | Karolinska InstitutetOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT06472063 | Upfront Surgery Versus NeoAdjuvant Chemotherapy Followed by Surgery for Resectable Advanced Gastric Cancer: SNAC Study(SNAC) | unknown | — | 684 | San Luigi Gonzaga HospitalOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT03293173 | Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis(Bio-CHIC) | unknown | Phase 2 | 120 | Nordic Lymphoma GroupNETWORK | 4 | Jun 21, 2024 | clinicaltrials |
| NCT03589924 | Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA)(IBBR) | unknown | N/A | 440 | Jiong WuOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT03942224 | Daratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma(DeRIVE) | unknown | Phase 2 | 49 | Emory UniversityOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT05060432 | Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors(TIG-006) | unknown | Phase 1 / Phase 2 | 153 | iTeos Belgium SAINDUSTRY | 6 | Jun 21, 2024 | clinicaltrials |
| NCT05444088 | Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 129 | Suzhou Suncadia Biopharmaceuticals Co., Ltd.INDUSTRY | 1 | Jun 21, 2024 | clinicaltrials |
| NCT05500846 | Targeted Cryoablation of Prostate Cancer Lesions: An Investigator-initiated Trial(PROCRY) | unknown | N/A | 51 | Osamu UkimuraOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT05819684 | A Study of SHR-4602 in Subjects With Advanced Malignant Solid Tumors | unknown | Phase 1 | 133 | Suzhou Suncadia Biopharmaceuticals Co., Ltd.INDUSTRY | 1 | Jun 21, 2024 | clinicaltrials |
| NCT05880992 | Trimodal Prehabilitation in Colorectal Cancer Patients(PrehabCRC) | unknown | N/A | 50 | Jordan LeitchOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06467565 | NALIRIFOX as Induction Therapy in LAPC | unknown | Phase 2 | 20 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06468254 | An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer | unknown | Phase 2 | 500 | Anhui Provincial Cancer HospitalOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06468293 | Role of Caregiver in the Clinical Pathway of Patients With Breast and Prostate Cancer | unknown | N/A | 102 | European Institute of OncologyOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06468566 | Identification of Benign and Malignant Breast Nodules Using Ultrasound-modulated Optical Tomography: A Multicenter Study | unknown | — | 2,000 | Xin-Wu CuiOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06468696 | Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients | unknown | N/A | 170 | Second Affiliated Hospital of Xi'an Jiaotong UniversityOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06469047 | Relationship Between Serum N/OFQ and Acute Myeloid Cell Leukemia(RBSNAAMCL) | unknown | — | 80 | Second Hospital of Shanxi Medical UniversityOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06469268 | Development and Application Study of ePRO Software for Managing Cancer Patients Throughout the Treatment Period | unknown | N/A | 100 | Shikai WuOTHER | 1 | Jun 21, 2024 | clinicaltrials |
| NCT06469671 | Effectiveness of Artificial Intelligence - Assisted Colonoscopy in Colorectal Neoplasms(ArtInCol) | unknown | N/A | 1,000 | State Scientific Centre of Coloproctology, Russian FederationOTHER_GOV | 1 | Jun 21, 2024 | clinicaltrials |
| NCT02977468 | Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer(Pembro/IORT) | unknown | Phase 1 | 15 | Eileen ConnollyOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT05240625 | Clinical Efficacy Evaluation of a Computer-aided Colonoscopy as Compared With the Standard Colonoscopy. | unknown | N/A | 1,500 | National Taiwan University HospitalOTHER | 1 | Jun 20, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Jun 28, 2024source: clinicaltrials